Recruiting

A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(5 sites)

United States

University Hospitals Cleveland Medical Center, Cleveland, Ohio

Oregon Health and Science University, Portland, Oregon

University of Pennsylvania, Philadelphia, Pennsylvania

Canada

The Ottawa Hospital Research Institute, Ottawa, Ontario

Groupe de Recherche en Maladies Osseuses (G.R.M.O.) Inc., Québec, Quebec